These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 27071765

  • 1. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.
    Meyer MR, Bergstrand MP, Helander A, Beck O.
    Anal Bioanal Chem; 2016 May; 408(13):3571-91. PubMed ID: 27071765
    [Abstract] [Full Text] [Related]

  • 2. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M, Helander A, Hansson T, Beck O.
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [Abstract] [Full Text] [Related]

  • 3. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
    El Balkhi S, Chaslot M, Picard N, Dulaurent S, Delage M, Mathieu O, Saint-Marcoux F.
    Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
    [Abstract] [Full Text] [Related]

  • 4. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
    Bäckberg M, Pettersson Bergstrand M, Beck O, Helander A.
    Clin Toxicol (Phila); 2019 Mar; 57(3):203-212. PubMed ID: 30348014
    [Abstract] [Full Text] [Related]

  • 5. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
    Pettersson Bergstrand M, Richter LHJ, Maurer HH, Wagmann L, Meyer MR.
    Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
    [Abstract] [Full Text] [Related]

  • 6. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
    Pettersson Bergstrand M, Meyer MR, Beck O, Helander A.
    Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
    [Abstract] [Full Text] [Related]

  • 7. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Tyrkkö E, Pelander A, Ketola RA, Ojanperä I.
    Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
    [Abstract] [Full Text] [Related]

  • 8. Urine analysis of 28 designer benzodiazepines by liquid chromatography-high-resolution mass spectrometry.
    Pettersson Bergstrand M, Beck O, Helander A.
    Clin Mass Spectrom; 2018 Dec; 10():25-32. PubMed ID: 39193360
    [Abstract] [Full Text] [Related]

  • 9. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT, Helfer AG, Michely JA, Auwärter V, Brandt SD, Meyer MR, Maurer HH.
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [Abstract] [Full Text] [Related]

  • 10. Intoxication cases associated with the novel designer drug 3',4'-methylenedioxy-α-pyrrolidinohexanophenone and studies on its human metabolism using high-resolution mass spectrometry.
    Grapp M, Kaufmann C, Schwelm HM, Neukamm MA, Blaschke S, Eidizadeh A.
    Drug Test Anal; 2020 Sep; 12(9):1320-1335. PubMed ID: 32476242
    [Abstract] [Full Text] [Related]

  • 11. Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project.
    Helander A, Bäckberg M, Signell P, Beck O.
    Clin Toxicol (Phila); 2017 Jul; 55(6):589-599. PubMed ID: 28349714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Paul M, Bleicher S, Guber S, Ippisch J, Polettini A, Schultis W.
    J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
    [Abstract] [Full Text] [Related]

  • 17. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
    Moosmann B, Bisel P, Westphal F, Wilde M, Kempf J, Angerer V, Auwärter V.
    Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
    [Abstract] [Full Text] [Related]

  • 18. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry.
    Peters RJ, van Engelen MC, Touber ME, Georgakopoulus C, Nielen MW.
    Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2329-37. PubMed ID: 19575408
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH.
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.